Although a role for ONECUT2 in cancer is not well defined, there is evidence that the expression of this gene is aberrantly upregulated in a variety of cancers including hepatocellular carcinoma, prostate cancer, colorectal cancer, and ovarian cancer, suggesting a role for this transcription factor in the modulation of cancer progression (45). This evidence concerns the gene ONECUT2 and prostate carcinoma.